Drugs / RO7763505
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07495813 | Mar 2026 → Feb 2028 expected | coronary artery disorder | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7763505 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07495813 ↗ |